| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 784.70 | 810.10 | 87.75 | 2,709.50 |
| Sale of Products | 638.40 | 685.60 | 0.00 | 2,687.45 |
| Sale of Services | 116.80 | 88.80 | 87.75 | 0.62 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 5,942.00 | 5,971.50 | 5,668.35 | 5,227.96 |
| Property, Plant and Equipments | 2,157.80 | 2,297.50 | 2,201.26 | 2,007.92 |
| Right-of-Use Assets | 277.00 | 294.40 | 298.02 | 289.49 |
| Intangible Assets | 2,656.40 | 2,591.40 | 2,371.34 | 2,311.33 |
| Market Cap (Rs in Crs) | 15,478.38 | |
|---|---|---|
| P/E | 314.45 | |
| Book Value (Rs) | 144.30 | |
| Div (%) | 500 | |
| Market Lot | 1 | |
| EPS (TTM) | 3.09 | |
|---|---|---|
| Price/Book | 6.73 | |
| Div Yield.(%) | 0.51 | |
| Face value (RS) | 1 | |
| Deliverables (%) | 29.03 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 4,24,706.28 | 1,770.10 | 1,714.25 | 3.26 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,52,945.74 | 5,761.35 | 5,663.30 | 1.73 | 6,448.75 - 3,455.00 |
| Cipla Ltd | 1,20,750.87 | 1,495.15 | 1,452.70 | 2.92 | 1,702.00 - 1,317.60 |
| Torrent Pharmac... | 1,09,983.06 | 3,249.80 | 3,209.35 | 1.26 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 1,00,167.88 | 2,427.85 | 2,421.15 | 0.28 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 2,88,49,472 | 18.11 |
| Total Institutions | 1,11,12,576 | 6.98 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 50,35,059 | 3.16 |
| Total Promoters | 8,07,17,056 | 50.68 |
| Total Public & others | 33566976 | 21.07 |
| Total | 15,92,81,139 | 100 |
